Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M I Traver

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Wisconsin Medical Journal|April 1, 1979
Therapeutic plasmapheresisP C Raich, M I Traver
Journal of Thrombosis and Haemostasis : JTH|May 20, 2008
Delayed adverse vascular events after splenectomy in hereditary spherocytosisR F Schilling, R E Gangnon, M I Traver
Transfusion|January 1, 1980
A computer-based record system for a hospital transfusion serviceA A Eggert, M I Traver, T J Blankenheim
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1986
A comparison of the predictive value and diagnostic efficiency of FHAP and CEA as cancer markersR A Bowser-Finn, L Kahan, F C Larson, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Wisconsin Medical Journal|April 1, 1979
Therapeutic plasmapheresisP C Raich, M I Traver
Journal of Thrombosis and Haemostasis : JTH|May 20, 2008
Delayed adverse vascular events after splenectomy in hereditary spherocytosisR F Schilling, R E Gangnon, M I Traver
Transfusion|January 1, 1980
A computer-based record system for a hospital transfusion serviceA A Eggert, M I Traver, T J Blankenheim
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1986
A comparison of the predictive value and diagnostic efficiency of FHAP and CEA as cancer markersR A Bowser-Finn, L Kahan, F C Larson, et al.
Pageof 1